Y2F-20776-06905
1 vaccination
2 coded responses
16 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 028 / RI
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Registered in v-safe
-
2021-03-10
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-10
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Chills, Fatigue or tirednessAdult check-in
-
2021-03-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-03-13
- 2021-03-14
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-15
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-03-16
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-09
- 2021-04-14
- 2021-04-21
- 2021-06-09
-
2021-09-08
Survey response — 6 months, dose 1MedDRA: Gestational hypertension — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Gestational hypertensionMedDRA releases: 2024-11 · check-in free text available
-
2021-09-08
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-09
-
2022-03-10
Survey response — 12 months, dose 1MedDRA: Gastritis, Ovarian cyst — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Gastritis, ovarian cystMedDRA releases: 2024-11 · check-in free text available
-
2022-03-10
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-15 | priority 2/3 | |
| 2021-09-08 | Unsuccessful | |
| 2022-03-10 | Unsuccessful |
Free text
Release 9 — 6 months, dose 1
Symptoms: Gestational hypertension
Release 11 — 12 months, dose 1
Symptoms: Gastritis, ovarian cyst
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastritis | · | · | ✓ |
| SD | Gestational hypertension | · | · | ✓ |
| SD | Ovarian cyst | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release